BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10938228)

  • 1. PACAP contributes to insulin secretion after gastric glucose gavage in mice.
    Filipsson K; Holst JJ; Ahrén B
    Am J Physiol Regul Integr Comp Physiol; 2000 Aug; 279(2):R424-32. PubMed ID: 10938228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice.
    Ahrén B; Hughes TE
    Endocrinology; 2005 Apr; 146(4):2055-9. PubMed ID: 15604213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice.
    Filipsson K; Pacini G; Scheurink AJ; Ahrén B
    Am J Physiol; 1998 May; 274(5):E834-42. PubMed ID: 9612241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of stimulators such as GLP-1, PACAP, and nicotinamide on glucose-stimulated insulin secretion from porcine pancreatic endocrine cells in long-term culture.
    Sato A; Wang PC; Ohgawara H
    Pancreas; 2002 Jul; 25(1):86-93. PubMed ID: 12131777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F; Fehmann HC; Göke R; Göke B
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse.
    Fridolf T; Sundler F; Ahrén B
    Cell Tissue Res; 1992 Aug; 269(2):275-9. PubMed ID: 1423494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose dependence of insulinotropic actions of pituitary adenylate cyclase-activating polypeptide in insulin-secreting INS-1 cells.
    Rosengren A; Filipsson K; Jing XJ; Reimer MK; Renström E
    Pflugers Arch; 2002 Jul; 444(4):556-67. PubMed ID: 12136276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and intracellular calcium responsiveness to glucagon-like peptide-1 and pituitary adenylate cyclase-activating peptide by dispersed adult porcine islet cells.
    Davalli AM; Bertuzzi F; Meoni C; Scaglia L; Socci C; Pozza G; Pontiroli AE
    Transplantation; 1999 Jan; 67(1):174-6. PubMed ID: 9921815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice.
    Ahrén B
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R269-72. PubMed ID: 14707011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pituitary adenylate cyclase-activating polypeptide on exocrine and endocrine secretion in the ovine pancreas.
    Onaga T; Uchida M; Kimura M; Miyazaki M; Mineo H; Kato S; Zabielski R
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1996 Nov; 115(3):185-93. PubMed ID: 9375356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice.
    Degerman E; Manganiello V; Holst JJ; Ahrén B
    Eur J Pharmacol; 2004 Sep; 498(1-3):319-23. PubMed ID: 15364011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase-activating peptide (PACAP): assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potential.
    Green BD; Irwin N; Flatt PR
    Peptides; 2006 Jun; 27(6):1349-58. PubMed ID: 16406202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion in rats.
    Yada T; Sakurada M; Ishihara H; Nakata M; Shioda S; Yaekura K; Hamakawa N; Yanagida K; Kikuchi M; Oka Y
    J Physiol; 1997 Dec; 505 ( Pt 2)(Pt 2):319-28. PubMed ID: 9423175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38).
    Tornøe K; Hannibal J; Fahrenkrug J; Holst JJ
    Am J Physiol; 1997 Aug; 273(2 Pt 1):G436-46. PubMed ID: 9277423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans.
    Filipsson K; Tornøe K; Holst J; Ahrén B
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3093-8. PubMed ID: 9284750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic endocrine responses to the peptides VIP and PACAP in the conscious calf.
    Edwards AV; Bloom SR; Ghatei MA
    Exp Physiol; 1997 Jul; 82(4):717-27. PubMed ID: 9257114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.
    Ahrén B; Pacini G
    Am J Physiol; 1999 Dec; 277(6):E996-E1004. PubMed ID: 10600787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of PACAP as a regulator of insulin secretion in pancreatic islets.
    Yada T; Sakurada M; Nakata M; Ihida K; Yaekura K; Shioda S; Kikuchi M
    Ann N Y Acad Sci; 1996 Dec; 805():329-40; discussion 341-2. PubMed ID: 8993414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice.
    Ahrén B; Holst JJ; Yu S
    Eur J Pharmacol; 2000 May; 397(1):219-25. PubMed ID: 10844116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.